关键词：巨细胞病毒性视网膜炎；病毒性炎症；巨细胞病毒；疱疹病毒；感光细胞
摘 要：Cytomegalovirus retinitis is a viral inflammation of the retina. The disease is caused by cytomegalovirus, a herpes virus that attacks the photosensitive cells in the retina. If left untreated, the disease can lead to permanent blindness. Most people are exposed to cytomegalovirus at some point in their life, but the infection usually affects those with a weakened immune system such as HIV-positive patients. There are two forms of cytomegalovirus retinitis: indolent and fulminant. Some common symptoms of cytomegalovirus retinitis include blurred vision, seeing floaters, photophobia, and blind spots.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

03.2.1 Product Profiles

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast .

06.3 Five Forces Analysis

07. Market Segmentation by Route of

Administration

07.1.1 Systemic

07.1.2 Ocular

08. Market Segmentation by Dosage Form

08.1.1 Capsule

08.1.2 Implant

08.1.3 Solution 8

08.1.4 Tablet

09. Market Assessment of Valcyte

10. Rate of Incidence and Prevalence

11. Geographical Segmentation

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Mergers and Acquisitions

19.2 Market Share Analysis 2013

19.3 Other Prominent Vendors

20. Key Vendor Analysis

20.1 F. Hoffmann-La Roche

20.1.1 Business Overview

20.1.2 Business Segmentation

20.1.3 Key Information

20.1.4 SWOT Analysis

20.2 Gilead Sciences

20.2.1 Business Overview

20.2.2 SWOT Analysis

20.3 Hospira

20.3.1 Business Overview

20.3.2 Business Segmentation

20.3.3 Key Information

20.3.4 SWOT Analysis

20.4 Shire

20.4.1 Business Overview

20.4.2 Key Information

20.4.3 SWOT Analysis

21. Other Reports in this Series